T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Williams-Sonoma
WSM
$24.8B
| $20.2M | ﹤0.01% |
200,308
-15,500
| -7% | -$1.56M |
|
952
Red Rock Resorts
RRR
$3.67B
| $20.2M | ﹤0.01% |
378,558
-383,651
| -50% | -$20.5M |
|
953
A.O. Smith
AOS
$10.4B
| $20.2M | ﹤0.01% |
244,520
-100,845
| -29% | -$8.31M |
|
954
Caesars Entertainment
CZR
$5.39B
| $20.1M | ﹤0.01% |
429,097
-46,582
| -10% | -$2.18M |
|
955
Catalyst Pharmaceutical
CPRX
$2.48B
| $20.1M | ﹤0.01% |
1,196,558
+18,390
| +2% | +$309K |
|
956
The Mosaic Company
MOS
$10.7B
| $19.9M | ﹤0.01% |
557,681
+20,372
| +4% | +$728K |
|
957
Virtus Investment Partners
VRTS
$1.36B
| $19.8M | ﹤0.01% |
81,855
-4,602
| -5% | -$1.11M |
|
958
Kellanova
K
$27.7B
| $19.7M | ﹤0.01% |
352,540
-13,293
| -4% | -$743K |
|
959
Prime Medicine
PRME
$727M
| $19.7M | ﹤0.01% |
2,221,159
+47,788
| +2% | +$423K |
|
960
Amicus Therapeutics
FOLD
$2.47B
| $19.5M | ﹤0.01% |
1,377,358
-19,737
| -1% | -$280K |
|
961
Valvoline
VVV
$5.15B
| $19.5M | ﹤0.01% |
519,849
-154,278
| -23% | -$5.8M |
|
962
RB Global
RBA
$22B
| $19.5M | ﹤0.01% |
291,816
+72,604
| +33% | +$4.86M |
|
963
Nordson
NDSN
$12.8B
| $19.4M | ﹤0.01% |
73,531
+915
| +1% | +$242K |
|
964
Bunge Global
BG
$16.4B
| $19.4M | ﹤0.01% |
192,186
-1,231,829
| -87% | -$124M |
|
|
AUTL
965
Autolus Therapeutics
AUTL
$381M
| $19.3M | ﹤0.01% |
+3,001,208
| New | +$19.3M |
|
|
MRO
966
DELISTED
Marathon Oil Corporation
MRO
| $19.1M | ﹤0.01% |
791,762
-37,067
| -4% | -$896K |
|
967
W.R. Berkley
WRB
$28B
| $19.1M | ﹤0.01% |
404,732
+11,321
| +3% | +$534K |
|
968
KeyCorp
KEY
$21B
| $19M | ﹤0.01% |
1,318,751
-501,143
| -28% | -$7.22M |
|
969
Symbotic
SYM
$5.44B
| $18.9M | ﹤0.01% |
369,026
+8,058
| +2% | +$414K |
|
970
Reinsurance Group of America
RGA
$12.9B
| $18.9M | ﹤0.01% |
116,872
-32,024
| -22% | -$5.18M |
|
971
Protagonist Therapeutics
PTGX
$3.71B
| $18.9M | ﹤0.01% |
823,740
-8,253
| -1% | -$189K |
|
972
WEX
WEX
$6.04B
| $18.5M | ﹤0.01% |
94,883
-290
| -0.3% | -$56.4K |
|
973
Warner Music
WMG
$17.8B
| $18.3M | ﹤0.01% |
511,952
+2,054
| +0.4% | +$73.5K |
|
974
LKQ Corp
LKQ
$8.47B
| $18.2M | ﹤0.01% |
381,808
+14,120
| +4% | +$675K |
|
975
J.M. Smucker
SJM
$11.8B
| $18.2M | ﹤0.01% |
144,067
+11,537
| +9% | +$1.46M |
|